AI Agent Operational Lift for Stratus in Irving, Texas

Why AI matters at this scale

Stratus Neuro operates in the specialized, high-acuity niche of neurodiagnostic services — a field where diagnostic precision directly dictates patient outcomes and revenue integrity. With 201-500 employees, the company has crossed the critical threshold where manual workflows become a bottleneck to growth, yet it remains nimble enough to deploy AI without the bureaucratic inertia of a mega-health system. This size band is the AI sweet spot: enough patient volume to train and validate models, enough IT maturity to integrate cloud-based solutions, and enough competitive pressure to differentiate on speed and accuracy.

Neurology faces a perfect storm. The US has a projected shortfall of 19,000 neurologists by 2025, while the burden of Alzheimer’s, epilepsy, and stroke grows relentlessly. AI isn’t a luxury here — it’s a force multiplier. For Stratus, AI adoption can transform from a cost-center IT project into a revenue-generating clinical service line.

Three concrete AI opportunities with ROI framing

1. Automated EEG screening and triage. Routine EEGs make up 60-70% of neurodiagnostic volume, yet most are normal. An AI model trained on Stratus’s own annotated studies can pre-screen these recordings, flagging only abnormal or ambiguous cases for neurologist review. Assuming 15,000 annual EEGs and a 50% reduction in review time per normal study, the practice could reclaim 2,000+ neurologist hours yearly — time reallocated to complex consults or expanded patient panels. At an average neurologist hourly cost of $200, that’s $400,000 in annual productivity gains.

2. Quantitative MRI reporting as a billable service. Referring physicians increasingly expect volumetric brain reports for dementia and multiple sclerosis workups. AI tools that segment brain structures and quantify atrophy can generate these reports in minutes rather than hours. Stratus can bill the technical component (TC) of advanced imaging post-processing, creating a new revenue stream of $50-150 per study. With 5,000 annual brain MRIs, this represents $250,000-$750,000 in incremental annual revenue with near-zero marginal cost.

3. Ambient clinical intelligence for encounter documentation. Neurologists spend 40% of their clinic day on EHR documentation. Deploying an AI ambient scribe that listens to patient visits and drafts structured notes can save 2-3 hours per clinician daily. For a group of 15 neurologists, that’s 30-45 hours recovered per day — equivalent to adding 4-5 full-time clinicians without hiring. The ROI is immediate: improved physician satisfaction, higher patient throughput, and reduced turnover costs that can exceed $250,000 per departing neurologist.

Deployment risks specific to this size band

Mid-market healthcare organizations face unique AI risks. First, data governance maturity often lags behind technical ambition. Stratus must ensure its AI vendors sign HIPAA Business Associate Agreements and that neuroimaging data — which can be re-identified from facial reconstruction — is processed in compliant environments. Second, change management is harder than in startups. Neurologists are skeptical of black-box algorithms; success requires transparent AI that shows its work and a clinical champion who co-designs workflows. Third, integration complexity with existing EEG software (Natus, Persyst) and EHRs (Epic, Cerner) can stall deployments. A phased approach — starting with a single, high-ROI use case like EEG triage — builds credibility and IT muscle before scaling. Finally, reimbursement uncertainty for AI-only services means Stratus should initially target AI that enhances existing billable procedures rather than standalone AI interpretations.